All posts by: Michael Zand

Tackling food allergies: is immunotherapy the answer? – News-Medical.net

News-Medical.netTackling food allergies: is immunotherapy the answer?News-Medical.netImmunotherapy is a form of allergen specific desensitization. It has been practised for many decades to treat allergic rhinoconjunctivitis especially in relation to ha… Continue reading

CRISPR-based tech offers breakthrough in diabetes, obesity treatment – domain-B

Tech TimesCRISPR-based tech offers breakthrough in diabetes, obesity treatmentdomain-BGene-editing technology CRISPR has scored another hit, as researchers claim a new form of gene therapy administered through skin transplants using CRISPR can help imp… Continue reading

Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month – Markets Insider

Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next MonthMarkets InsiderCompugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy,… Continue reading

Mice made with CRISPR usher in new era of autism research – Spectrum

SpectrumMice made with CRISPR usher in new era of autism researchSpectrumResearchers have debuted two mouse models of autism made using the gene-editing tool CRISPR. Both strains lack one functional copy of CHD8, a gene with strong ties to autism. … Continue reading

Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next Month – PR Newswire (press release)

Compugen to Present at the CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference Next MonthPR Newswire (press release)Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer im… Continue reading

Bristol-Myers Squibb bags immunotherapy unicorn – Chemistry World (subscription)